Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE: 000766)

Market Cap	13.99B
Revenue (ttm)	1.47B
Net Income (ttm)	43.93M
Shares Out	966.49M
EPS (ttm)	0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,587,000
Open	15.18
Previous Close	14.63
Day's Range	14.22 - 15.18
52-Week Range	7.84 - 24.51
Beta	0.27
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. engages in the research, development, manufacture, and sale of traditional Chinese medicine, Chinese and western raw materials, and biochemical preparations in China. The company offers traditional Chinese medicines, such as anticancer, gynecological, Rheumatic, osteopathy, urology, heat-clearing and detoxifying, cardiovascular, digestive, strengthening and tonic, respiratory, diabetes, senses, and pediatric medication products, as well as Western medicines. Tonghua Golden-Horse Pharmaceuti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 1,696
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000766

Financial Performance

In 2023, Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd's revenue was 1.47 billion, an increase of 0.18% compared to the previous year's 1.47 billion. Earnings were 43.93 million, an increase of 45.71%.